相关实验视频
Updated: Jan 13, 2026

Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
一个纳米系统将线粒体损伤与微管稳定结合起来,用于抑制癌症转移
Zhanghan Wu1, Jing Tao1, Yuan Yao1
1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial Technology, West China School of Pharmacy, Sichuan University, No. 17, Block 3, South Renmin Road, Chengdu 610041, P.R. China. zhou_zhou610@163.com.
这项研究引入了一种新的纳米系统,将线粒体损伤和微管稳定结合起来,以对抗癌症转移. 双作用方法显著抑制瘤细胞迁移和入侵,提供了一个有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 纳米技术 纳米技术
- 细胞生物学 细胞生物学
背景情况:
- 线粒体向是已知的癌症治疗策略,但它对转移的有效性有限.
- 线粒体和微管体之间的相互作用对于癌细胞的功能和迁移至关重要.
- 开发有效的癌症转移治疗方法仍然是一个重大的临床挑战.
研究的目的:
- 为癌症转移治疗开发和评估一个主动向纳米系统.
- 为了研究线粒体损伤和微管稳定结合的协同效应.
- 阐明纳米系统抗转移活动的潜在机制.
主要方法:
- 制备一种纳米系统,同时提供线粒体损伤药物和微管稳定剂.
- 在体外评估协同性细胞毒性,瘤细胞迁移和侵袭抑制.
- 在临床前模型中对肺转移抑制的体内评估.
- 涉及活性氧物种,腺三酸盐水平,线粒体动力学和上皮-介质酶过渡标志物的机制研究.
主要成果:
- 该纳米系统在实验室中证明了对癌细胞的协同细胞毒性.
- 与单剂治疗相比,观察到显著抑制瘤细胞迁移和入侵.
- 在体内研究显示,超过85%的肺转移被抑制.
- 纳米系统通过增加活性氧物种和减少腺三酸盐诱导线粒体损伤,而微管稳定抑制了线粒体裂变.
结论:
- 通过纳米系统结合线粒体损伤和微管稳定提供了对抗癌症转移的有效策略.
- 该纳米系统通过准线粒体功能和微管子动态,有效地抑制瘤细胞迁移和入侵.
- 这种组合疗法为管理和治疗转移性癌症提供了有希望的方法.
更多相关视频
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
08:57Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice
Published on: October 5, 2017
相关概念视频
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Destabilization of Microtubules
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...